img

Global TDS(Transdermal Delivery Systems) Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 340 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global TDS(Transdermal Delivery Systems) Sales Market Report 2024

The global TDS(Transdermal Delivery Systems) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global TDS(Transdermal Delivery Systems) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others


Segment by Application


Hospital
Clinic
Other

The TDS(Transdermal Delivery Systems) market is analysed and market size information is provided by regions (countries).

Segment by Application

, the TDS(Transdermal Delivery Systems) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Adhex Pharma
Harro Hofliger
Tesa Labtec
Toyochem
Teva Pharmaceutical
Pfizer
IBSA Group
Teikoku Seiyaku
Endo International
Hisamitsu
Mylan
Sorrento Therapeutics

Table of Content

1 TDS(Transdermal Delivery Systems) Market Overview
1.1 TDS(Transdermal Delivery Systems) Product Scope
1.2 TDS(Transdermal Delivery Systems) Segment by Type
1.2.1 Global TDS(Transdermal Delivery Systems) Sales by Type (2016 & 2021 & 2027)
1.2.2 Single-layer Drug-in-Adhesive
1.2.3 Multi-layer Drug-in-Adhesive
1.2.4 Others
1.3 TDS(Transdermal Delivery Systems) Segment by Application
1.3.1 Global TDS(Transdermal Delivery Systems) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 TDS(Transdermal Delivery Systems) Market Estimates and Forecasts (2016-2027)
1.4.1 Global TDS(Transdermal Delivery Systems) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global TDS(Transdermal Delivery Systems) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global TDS(Transdermal Delivery Systems) Price Trends (2016-2027)

2 TDS(Transdermal Delivery Systems) Estimates and Forecasts by Region
2.1 Global TDS(Transdermal Delivery Systems) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2016-2021)
2.2.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2016-2021)
2.3 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global TDS(Transdermal Delivery Systems) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.2 Europe TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.3 China TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.4 Japan TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.6 India TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
3 Global TDS(Transdermal Delivery Systems) Competition Landscape by Players
3.1 Global Top TDS(Transdermal Delivery Systems) Players by Sales (2016-2021)
3.2 Global Top TDS(Transdermal Delivery Systems) Players by Revenue (2016-2021)
3.3 Global TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2020)
3.4 Global TDS(Transdermal Delivery Systems) Average Price by Company (2016-2021)
3.5 Manufacturers TDS(Transdermal Delivery Systems) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global TDS(Transdermal Delivery Systems) Market Size by Type
4.1 Global TDS(Transdermal Delivery Systems) Historic Market Review by Type (2016-2021)
4.1.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
4.1.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type (2016-2021)
4.1.3 Global TDS(Transdermal Delivery Systems) Price by Type (2016-2021)
4.2 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2022-2027)
4.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Type (2022-2027)
4.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Type (2022-2027)
5 Global TDS(Transdermal Delivery Systems) Market Size by Application
5.1 Global TDS(Transdermal Delivery Systems) Historic Market Review by Application (2016-2021)
5.1.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
5.1.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2016-2021)
5.1.3 Global TDS(Transdermal Delivery Systems) Price by Application (2016-2021)
5.2 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2022-2027)
5.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Application (2022-2027)
5.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Application (2022-2027)

6 North America TDS(Transdermal Delivery Systems) Market Facts & Figures
6.1 North America TDS(Transdermal Delivery Systems) Sales by Company
6.1.1 North America TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
6.1.2 North America TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
6.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type
6.2.1 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
6.2.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
6.3 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application
6.3.1 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2016-2021)
6.3.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2022-2027)

7 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures
7.1 Europe TDS(Transdermal Delivery Systems) Sales by Company
7.1.1 Europe TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
7.1.2 Europe TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
7.2 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type
7.2.1 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
7.2.2 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
7.3 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China TDS(Transdermal Delivery Systems) Market Facts & Figures
8.1 China TDS(Transdermal Delivery Systems) Sales by Company
8.1.1 China TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
8.1.2 China TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
8.2 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type
8.2.1 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
8.2.2 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
8.3 China TDS(Transdermal Delivery Systems) Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan TDS(Transdermal Delivery Systems) Market Facts & Figures
9.1 Japan TDS(Transdermal Delivery Systems) Sales by Company
9.1.1 Japan TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
9.1.2 Japan TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
9.2 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type
9.2.1 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
9.2.2 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
9.3 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia TDS(Transdermal Delivery Systems) Market Facts & Figures
10.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales by Company
10.1.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
10.1.2 Southeast Asia TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
10.2 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type
10.2.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India TDS(Transdermal Delivery Systems) Market Facts & Figures
11.1 India TDS(Transdermal Delivery Systems) Sales by Company
11.1.1 India TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
11.1.2 India TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
11.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type
11.2.1 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
11.2.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
11.3 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application
11.3.1 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2016-2021)
11.3.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in TDS(Transdermal Delivery Systems) Business
12.1 Adhex Pharma
12.1.1 Adhex Pharma Corporation Information
12.1.2 Adhex Pharma Business Overview
12.1.3 Adhex Pharma TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
12.1.5 Adhex Pharma Recent Development
12.2 Harro Hofliger
12.2.1 Harro Hofliger Corporation Information
12.2.2 Harro Hofliger Business Overview
12.2.3 Harro Hofliger TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Harro Hofliger TDS(Transdermal Delivery Systems) Products Offered
12.2.5 Harro Hofliger Recent Development
12.3 Tesa Labtec
12.3.1 Tesa Labtec Corporation Information
12.3.2 Tesa Labtec Business Overview
12.3.3 Tesa Labtec TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Tesa Labtec TDS(Transdermal Delivery Systems) Products Offered
12.3.5 Tesa Labtec Recent Development
12.4 Toyochem
12.4.1 Toyochem Corporation Information
12.4.2 Toyochem Business Overview
12.4.3 Toyochem TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Toyochem TDS(Transdermal Delivery Systems) Products Offered
12.4.5 Toyochem Recent Development
12.5 Teva Pharmaceutical
12.5.1 Teva Pharmaceutical Corporation Information
12.5.2 Teva Pharmaceutical Business Overview
12.5.3 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Products Offered
12.5.5 Teva Pharmaceutical Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer TDS(Transdermal Delivery Systems) Products Offered
12.6.5 Pfizer Recent Development
12.7 IBSA Group
12.7.1 IBSA Group Corporation Information
12.7.2 IBSA Group Business Overview
12.7.3 IBSA Group TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 IBSA Group TDS(Transdermal Delivery Systems) Products Offered
12.7.5 IBSA Group Recent Development
12.8 Teikoku Seiyaku
12.8.1 Teikoku Seiyaku Corporation Information
12.8.2 Teikoku Seiyaku Business Overview
12.8.3 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Products Offered
12.8.5 Teikoku Seiyaku Recent Development
12.9 Endo International
12.9.1 Endo International Corporation Information
12.9.2 Endo International Business Overview
12.9.3 Endo International TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Endo International TDS(Transdermal Delivery Systems) Products Offered
12.9.5 Endo International Recent Development
12.10 Hisamitsu
12.10.1 Hisamitsu Corporation Information
12.10.2 Hisamitsu Business Overview
12.10.3 Hisamitsu TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hisamitsu TDS(Transdermal Delivery Systems) Products Offered
12.10.5 Hisamitsu Recent Development
12.11 Mylan
12.11.1 Mylan Corporation Information
12.11.2 Mylan Business Overview
12.11.3 Mylan TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Mylan TDS(Transdermal Delivery Systems) Products Offered
12.11.5 Mylan Recent Development
12.12 Sorrento Therapeutics
12.12.1 Sorrento Therapeutics Corporation Information
12.12.2 Sorrento Therapeutics Business Overview
12.12.3 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Products Offered
12.12.5 Sorrento Therapeutics Recent Development

13 TDS(Transdermal Delivery Systems) Manufacturing Cost Analysis
13.1 TDS(Transdermal Delivery Systems) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of TDS(Transdermal Delivery Systems)
13.4 TDS(Transdermal Delivery Systems) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 TDS(Transdermal Delivery Systems) Distributors List
14.3 TDS(Transdermal Delivery Systems) Customers

15 Market Dynamics
15.1 TDS(Transdermal Delivery Systems) Market Trends
15.2 TDS(Transdermal Delivery Systems) Drivers
15.3 TDS(Transdermal Delivery Systems) Market Challenges
15.4 TDS(Transdermal Delivery Systems) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global TDS(Transdermal Delivery Systems) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global TDS(Transdermal Delivery Systems) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global TDS(Transdermal Delivery Systems) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Region (2016-2021)
Table 5. Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2016-2021)
Table 6. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global TDS(Transdermal Delivery Systems) Revenue Share by Region (2016-2021)
Table 8. Global TDS(Transdermal Delivery Systems) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global TDS(Transdermal Delivery Systems) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global TDS(Transdermal Delivery Systems) Revenue Share Forecast by Region (2022-2027)
Table 12. Global TDS(Transdermal Delivery Systems) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global TDS(Transdermal Delivery Systems) Sales Share by Company (2016-2021)
Table 14. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global TDS(Transdermal Delivery Systems) Revenue Share by Company (2016-2021)
Table 16. Global TDS(Transdermal Delivery Systems) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2020)
Table 17. Global TDS(Transdermal Delivery Systems) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers TDS(Transdermal Delivery Systems) Manufacturing Sites and Area Served
Table 19. Manufacturers TDS(Transdermal Delivery Systems) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2016-2021)
Table 22. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2016-2021)
Table 23. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global TDS(Transdermal Delivery Systems) Price (USD/Unit) by Type (2016-2021)
Table 25. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2022-2027)
Table 26. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2022-2027)
Table 28. Global TDS(Transdermal Delivery Systems) Price (USD/Unit) by Type (2022-2027)
Table 29. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2016-2021)
Table 30. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2016-2021)
Table 31. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global TDS(Transdermal Delivery Systems) Price (USD/Unit) by Application (2016-2021)
Table 33. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2022-2027)
Table 34. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2022-2027)
Table 35. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global TDS(Transdermal Delivery Systems) Revenue Share by Application (2022-2027)
Table 37. Global TDS(Transdermal Delivery Systems) Price (USD/Unit) by Application (2022-2027)
Table 38. North America TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021)
Table 39. North America TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021)
Table 40. North America TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021)
Table 42. North America TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units)
Table 43. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
Table 44. North America TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units)
Table 45. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027)
Table 46. North America TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units)
Table 47. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
Table 48. North America TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units)
Table 49. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027)
Table 50. Europe TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021)
Table 51. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021)
Table 52. Europe TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021)
Table 54. Europe TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units)
Table 55. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
Table 56. Europe TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units)
Table 57. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027)
Table 58. Europe TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units)
Table 59. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
Table 60. Europe TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units)
Table 61. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027)
Table 62. China TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021)
Table 63. China TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021)
Table 64. China TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021)
Table 66. China TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units)
Table 67. China TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
Table 68. China TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units)
Table 69. China TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027)
Table 70. China TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units)
Table 71. China TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
Table 72. China TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units)
Table 73. China TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027)
Table 74. Japan TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021)
Table 75. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021)
Table 76. Japan TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021)
Table 78. Japan TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units)
Table 79. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
Table 80. Japan TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units)
Table 81. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027)
Table 82. Japan TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units)
Table 83. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
Table 84. Japan TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units)
Table 85. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027)
Table 98. India TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021)
Table 99. India TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021)
Table 100. India TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021)
Table 102. India TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units)
Table 103. India TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
Table 104. India TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units)
Table 105. India TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027)
Table 106. India TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units)
Table 107. India TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
Table 108. India TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units)
Table 109. India TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027)
Table 110. Adhex Pharma Corporation Information
Table 111. Adhex Pharma Description and Business Overview
Table 112. Adhex Pharma TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Adhex Pharma TDS(Transdermal Delivery Systems) Product
Table 114. Adhex Pharma Recent Development
Table 115. Harro Hofliger Corporation Information
Table 116. Harro Hofliger Description and Business Overview
Table 117. Harro Hofliger TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Harro Hofliger TDS(Transdermal Delivery Systems) Product
Table 119. Harro Hofliger Recent Development
Table 120. Tesa Labtec Corporation Information
Table 121. Tesa Labtec Description and Business Overview
Table 122. Tesa Labtec TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Tesa Labtec TDS(Transdermal Delivery Systems) Product
Table 124. Tesa Labtec Recent Development
Table 125. Toyochem Corporation Information
Table 126. Toyochem Description and Business Overview
Table 127. Toyochem TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Toyochem TDS(Transdermal Delivery Systems) Product
Table 129. Toyochem Recent Development
Table 130. Teva Pharmaceutical Corporation Information
Table 131. Teva Pharmaceutical Description and Business Overview
Table 132. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Product
Table 134. Teva Pharmaceutical Recent Development
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Pfizer TDS(Transdermal Delivery Systems) Product
Table 139. Pfizer Recent Development
Table 140. IBSA Group Corporation Information
Table 141. IBSA Group Description and Business Overview
Table 142. IBSA Group TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. IBSA Group TDS(Transdermal Delivery Systems) Product
Table 144. IBSA Group Recent Development
Table 145. Teikoku Seiyaku Corporation Information
Table 146. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Teikoku Seiyaku Description and Business Overview
Table 148. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Product
Table 149. Teikoku Seiyaku Recent Development
Table 150. Endo International Corporation Information
Table 151. Endo International TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Endo International Description and Business Overview
Table 153. Endo International TDS(Transdermal Delivery Systems) Product
Table 154. Endo International Recent Development
Table 155. Hisamitsu Corporation Information
Table 156. Hisamitsu Description and Business Overview
Table 157. Hisamitsu TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Hisamitsu TDS(Transdermal Delivery Systems) Product
Table 159. Hisamitsu Recent Development
Table 160. Mylan Corporation Information
Table 161. Mylan Description and Business Overview
Table 162. Mylan TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Mylan TDS(Transdermal Delivery Systems) Product
Table 164. Mylan Recent Development
Table 165. Sorrento Therapeutics Corporation Information
Table 166. Sorrento Therapeutics Description and Business Overview
Table 167. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Product
Table 169. Sorrento Therapeutics Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. TDS(Transdermal Delivery Systems) Distributors List
Table 173. TDS(Transdermal Delivery Systems) Customers List
Table 174. TDS(Transdermal Delivery Systems) Market Trends
Table 175. TDS(Transdermal Delivery Systems) Market Drivers
Table 176. TDS(Transdermal Delivery Systems) Market Challenges
Table 177. TDS(Transdermal Delivery Systems) Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. TDS(Transdermal Delivery Systems) Product Picture
Figure 2. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Other Examples
Figure 9. Global TDS(Transdermal Delivery Systems) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global TDS(Transdermal Delivery Systems) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global TDS(Transdermal Delivery Systems) Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global TDS(Transdermal Delivery Systems) Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America TDS(Transdermal Delivery Systems) Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China TDS(Transdermal Delivery Systems) Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest TDS(Transdermal Delivery Systems) Players Market Share by Revenue in TDS(Transdermal Delivery Systems): 2016 & 2020
Figure 28. TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2016-2021)
Figure 30. Global TDS(Transdermal Delivery Systems) Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global TDS(Transdermal Delivery Systems) Revenue Share by Application (2016-2021)
Figure 32. Global TDS(Transdermal Delivery Systems) Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020
Figure 34. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020
Figure 35. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020
Figure 36. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020
Figure 37. China TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020
Figure 38. China TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020
Figure 39. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020
Figure 40. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020
Figure 41. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020
Figure 42. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020
Figure 43. India TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020
Figure 44. India TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of TDS(Transdermal Delivery Systems)
Figure 47. Manufacturing Process Analysis of TDS(Transdermal Delivery Systems)
Figure 48. TDS(Transdermal Delivery Systems) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed